Bioheart (02185.HK) anuncia sus resultados clínicos para Iberis-HTN en CIT 2023 ...Middle East

PR Newswire - News
SHANGHÁI, 2 de julio de 2023 /PRNewswire/ -- Bioheart (02185.HK), junto con su filial Angiocare anuncia el resultado clínico de Iberis-HTN en China Interventional Therapeutics 2023. Iberis-HTN es un ensayo prospectivo, multicéntrico, ciego, aleatorizado y controlado para evaluar la...

Hence then, the article about bioheart 02185 hk anuncia sus resultados clinicos para iberis htn en cit 2023 was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Bioheart (02185.HK) anuncia sus resultados clínicos para Iberis-HTN en CIT 2023 )

Apple Storegoogle play

Last updated :

Also on site :